Selected research
Market Outlook & Growth Opportunities
Global Std Self Diagnostics Market Outlook and Growth Opportunities 2026
Market perspective
The global Std Self Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Std Self Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Std Self Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Std Self Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Std Self Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Std Self Diagnostics market include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Std Self Diagnostics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Std Self Diagnostics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Std Self Diagnostics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Std Self Diagnostics market.
Std Self Diagnostics Segment by Company
Orasure
Hologic Inc.
F. Hoffmann-La Roche
DiaSorin
Danaher Corporation
Cepheid Inc.
Bio-Rad Laboratories
BioMerieux
Becton Dickinson and Company
Alere Inc.
Affymetrix
Abbott Laboratories
Std Self Diagnostics Segment by Type
Testing Kit
Testing Device
Testing Strip/chip
Std Self Diagnostics Segment by Application
Diagnostic Centres
Hospitals
Homecare
Others
Std Self Diagnostics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Std Self Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Std Self Diagnostics key companies, revenue, market share, and recent developments.
3. To split the Std Self Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Std Self Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Std Self Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze Std Self Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Std Self Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Std Self Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Std Self Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Std Self Diagnostics industry.
Chapter 3: Detailed analysis of Std Self Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Std Self Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Std Self Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Std Self Diagnostics Industry Trends
Table 2. Std Self Diagnostics Industry Drivers
Table 3. Std Self Diagnostics Industry Opportunities and Challenges
Table 4. Std Self Diagnostics Industry Restraints
Table 5. Global Std Self Diagnostics Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Std Self Diagnostics Revenue Share by Company (2021-2026)
Table 7. Global Std Self Diagnostics Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Std Self Diagnostics Key Company Manufacturing Base & Headquarters
Table 9. Global Std Self Diagnostics Company, Product Type & Application
Table 10. Global Std Self Diagnostics Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Std Self Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Testing Kit
Table 15. Significant Companies of Testing Device
Table 16. Significant Companies of Testing Strip/chip
Table 17. Global Std Self Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Std Self Diagnostics Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Std Self Diagnostics Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Std Self Diagnostics Sales Value Share by Type (2021-2026)
Table 21. Global Std Self Diagnostics Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Diagnostic Centres
Table 23. Significant Companies of Hospitals
Table 24. Significant Companies of Homecare
Table 25. Significant Companies of Others
Table 26. Global Std Self Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Std Self Diagnostics Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global Std Self Diagnostics Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global Std Self Diagnostics Sales Value Share by Application (2021-2026)
Table 30. Global Std Self Diagnostics Sales Value Share by Application (2027-2032)
Table 31. Global Std Self Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Std Self Diagnostics Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global Std Self Diagnostics Sales Value Share by Region (2021-2026)
Table 34. Global Std Self Diagnostics Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global Std Self Diagnostics Sales Value Share by Region (2027-2032)
Table 36. Global Std Self Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Std Self Diagnostics Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global Std Self Diagnostics Sales Value Market Share by Country (2021-2026)
Table 39. Global Std Self Diagnostics Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global Std Self Diagnostics Sales Value Market Share by Country (2027-2032)
Table 41. Orasure Company Information
Table 42. Orasure Business Overview
Table 43. Orasure Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Orasure Std Self Diagnostics Product Portfolio
Table 45. Orasure Recent Development
Table 46. Hologic Inc. Company Information
Table 47. Hologic Inc. Business Overview
Table 48. Hologic Inc. Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. Hologic Inc. Std Self Diagnostics Product Portfolio
Table 50. Hologic Inc. Recent Development
Table 51. F. Hoffmann-La Roche Company Information
Table 52. F. Hoffmann-La Roche Business Overview
Table 53. F. Hoffmann-La Roche Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. F. Hoffmann-La Roche Std Self Diagnostics Product Portfolio
Table 55. F. Hoffmann-La Roche Recent Development
Table 56. DiaSorin Company Information
Table 57. DiaSorin Business Overview
Table 58. DiaSorin Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. DiaSorin Std Self Diagnostics Product Portfolio
Table 60. DiaSorin Recent Development
Table 61. Danaher Corporation Company Information
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. Danaher Corporation Std Self Diagnostics Product Portfolio
Table 65. Danaher Corporation Recent Development
Table 66. Cepheid Inc. Company Information
Table 67. Cepheid Inc. Business Overview
Table 68. Cepheid Inc. Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. Cepheid Inc. Std Self Diagnostics Product Portfolio
Table 70. Cepheid Inc. Recent Development
Table 71. Bio-Rad Laboratories Company Information
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Bio-Rad Laboratories Std Self Diagnostics Product Portfolio
Table 75. Bio-Rad Laboratories Recent Development
Table 76. BioMerieux Company Information
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. BioMerieux Std Self Diagnostics Product Portfolio
Table 80. BioMerieux Recent Development
Table 81. Becton Dickinson and Company Company Information
Table 82. Becton Dickinson and Company Business Overview
Table 83. Becton Dickinson and Company Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. Becton Dickinson and Company Std Self Diagnostics Product Portfolio
Table 85. Becton Dickinson and Company Recent Development
Table 86. Alere Inc. Company Information
Table 87. Alere Inc. Business Overview
Table 88. Alere Inc. Std Self Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Alere Inc. Std Self Diagnostics Product Portfolio
Table 90. Alere Inc. Recent Development
Table 91. Affymetrix Company Information
Table 92. Affymetrix Business Overview
Table 93. Affymetrix Std Self Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Affymetrix Std Self Diagnostics Product Portfolio
Table 95. Affymetrix Recent Development
Table 96. Abbott Laboratories Company Information
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Std Self Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Abbott Laboratories Std Self Diagnostics Product Portfolio
Table 100. Abbott Laboratories Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Authors List of This Report
Table 103. Secondary Sources
Table 104. Primary Sources
List of Figures
Figure 1. Std Self Diagnostics Product Image
Figure 2. Global Std Self Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Std Self Diagnostics Market Size (2021-2032) & (US$ Million)
Figure 4. Global Std Self Diagnostics Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Testing Kit Image
Figure 8. Testing Device Image
Figure 9. Testing Strip/chip Image
Figure 10. Global Std Self Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Std Self Diagnostics Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Std Self Diagnostics Sales Value Share by Type (2021-2032)
Figure 13. Diagnostic Centres Image
Figure 14. Hospitals Image
Figure 15. Homecare Image
Figure 16. Others Image
Figure 17. Global Std Self Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global Std Self Diagnostics Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global Std Self Diagnostics Sales Value Share by Application (2021-2032)
Figure 20. Global Std Self Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global Std Self Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America Std Self Diagnostics Sales Value (2021-2032) & (US$ Million)
Figure 23. North America Std Self Diagnostics Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe Std Self Diagnostics Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe Std Self Diagnostics Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific Std Self Diagnostics Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific Std Self Diagnostics Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America Std Self Diagnostics Sales Value (2021-2032) & (US$ Million)
Figure 29. South America Std Self Diagnostics Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa Std Self Diagnostics Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa Std Self Diagnostics Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt Std Self Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- Testing Kit
- Testing Device
- Testing Strip/chip
Applications
- Diagnostic Centres
- Hospitals
- Homecare
- Others
Companies covered
- Orasure
- Hologic Inc.
- F. Hoffmann-La Roche
- DiaSorin
- Danaher Corporation
- Cepheid Inc.
- Bio-Rad Laboratories
- BioMerieux
- Becton Dickinson and Company
- Alere Inc.
- Affymetrix
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Std Self Diagnostics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Std Self Diagnostics Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Std Self Diagnostics Market Dynamics
- 2.1 Std Self Diagnostics Industry Trends
- 2.2 Std Self Diagnostics Industry Drivers
- 2.3 Std Self Diagnostics Industry Opportunities and Challenges
- 2.4 Std Self Diagnostics Industry Restraints
3 Std Self Diagnostics Market by Company
- 3.1 Global Std Self Diagnostics Company Revenue Ranking in 2025
- 3.2 Global Std Self Diagnostics Revenue by Company (2021-2026)
- 3.3 Global Std Self Diagnostics Company Ranking (2024-2026)
- 3.4 Global Std Self Diagnostics Company Manufacturing Base and Headquarters
- 3.5 Global Std Self Diagnostics Company Product Type and Application
- 3.6 Global Std Self Diagnostics Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Std Self Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Std Self Diagnostics Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Std Self Diagnostics Market by Type
- 4.1 Std Self Diagnostics Type Introduction
- 4.1.1 Testing Kit
- 4.1.2 Testing Device
- 4.1.3 Testing Strip/chip
- 4.2 Global Std Self Diagnostics Sales Value by Type
- 4.2.1 Global Std Self Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Std Self Diagnostics Sales Value by Type (2021-2032)
- 4.2.3 Global Std Self Diagnostics Sales Value Share by Type (2021-2032)
5 Std Self Diagnostics Market by Application
- 5.1 Std Self Diagnostics Application Introduction
- 5.1.1 Diagnostic Centres
- 5.1.2 Hospitals
- 5.1.3 Homecare
- 5.1.4 Others
- 5.2 Global Std Self Diagnostics Sales Value by Application
- 5.2.1 Global Std Self Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Std Self Diagnostics Sales Value by Application (2021-2032)
- 5.2.3 Global Std Self Diagnostics Sales Value Share by Application (2021-2032)
6 Std Self Diagnostics Regional Value Analysis
- 6.1 Global Std Self Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Std Self Diagnostics Sales Value by Region (2021-2032)
- 6.2.1 Global Std Self Diagnostics Sales Value by Region: 2021-2026
- 6.2.2 Global Std Self Diagnostics Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Std Self Diagnostics Sales Value (2021-2032)
- 6.3.2 North America Std Self Diagnostics Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Std Self Diagnostics Sales Value (2021-2032)
- 6.4.2 Europe Std Self Diagnostics Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Std Self Diagnostics Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Std Self Diagnostics Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Std Self Diagnostics Sales Value (2021-2032)
- 6.6.2 South America Std Self Diagnostics Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Std Self Diagnostics Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Std Self Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Std Self Diagnostics Country-level Value Analysis
- 7.1 Global Std Self Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Std Self Diagnostics Sales Value by Country (2021-2032)
- 7.2.1 Global Std Self Diagnostics Sales Value by Country (2021-2026)
- 7.2.2 Global Std Self Diagnostics Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.7.2 France Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.14.2 China Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.17.2 India Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Std Self Diagnostics Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Std Self Diagnostics Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Std Self Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Orasure
- 8.1.1 Orasure Company Information
- 8.1.2 Orasure Business Overview
- 8.1.3 Orasure Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.1.4 Orasure Std Self Diagnostics Product Portfolio
- 8.1.5 Orasure Recent Developments
- 8.2 Hologic Inc.
- 8.2.1 Hologic Inc. Company Information
- 8.2.2 Hologic Inc. Business Overview
- 8.2.3 Hologic Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.2.4 Hologic Inc. Std Self Diagnostics Product Portfolio
- 8.2.5 Hologic Inc. Recent Developments
- 8.3 F. Hoffmann-La Roche
- 8.3.1 F. Hoffmann-La Roche Company Information
- 8.3.2 F. Hoffmann-La Roche Business Overview
- 8.3.3 F. Hoffmann-La Roche Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.3.4 F. Hoffmann-La Roche Std Self Diagnostics Product Portfolio
- 8.3.5 F. Hoffmann-La Roche Recent Developments
- 8.4 DiaSorin
- 8.4.1 DiaSorin Company Information
- 8.4.2 DiaSorin Business Overview
- 8.4.3 DiaSorin Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.4.4 DiaSorin Std Self Diagnostics Product Portfolio
- 8.4.5 DiaSorin Recent Developments
- 8.5 Danaher Corporation
- 8.5.1 Danaher Corporation Company Information
- 8.5.2 Danaher Corporation Business Overview
- 8.5.3 Danaher Corporation Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.5.4 Danaher Corporation Std Self Diagnostics Product Portfolio
- 8.5.5 Danaher Corporation Recent Developments
- 8.6 Cepheid Inc.
- 8.6.1 Cepheid Inc. Company Information
- 8.6.2 Cepheid Inc. Business Overview
- 8.6.3 Cepheid Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.6.4 Cepheid Inc. Std Self Diagnostics Product Portfolio
- 8.6.5 Cepheid Inc. Recent Developments
- 8.7 Bio-Rad Laboratories
- 8.7.1 Bio-Rad Laboratories Company Information
- 8.7.2 Bio-Rad Laboratories Business Overview
- 8.7.3 Bio-Rad Laboratories Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.7.4 Bio-Rad Laboratories Std Self Diagnostics Product Portfolio
- 8.7.5 Bio-Rad Laboratories Recent Developments
- 8.8 BioMerieux
- 8.8.1 BioMerieux Company Information
- 8.8.2 BioMerieux Business Overview
- 8.8.3 BioMerieux Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.8.4 BioMerieux Std Self Diagnostics Product Portfolio
- 8.8.5 BioMerieux Recent Developments
- 8.9 Becton Dickinson and Company
- 8.9.1 Becton Dickinson and Company Company Information
- 8.9.2 Becton Dickinson and Company Business Overview
- 8.9.3 Becton Dickinson and Company Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.9.4 Becton Dickinson and Company Std Self Diagnostics Product Portfolio
- 8.9.5 Becton Dickinson and Company Recent Developments
- 8.10 Alere Inc.
- 8.10.1 Alere Inc. Company Information
- 8.10.2 Alere Inc. Business Overview
- 8.10.3 Alere Inc. Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.10.4 Alere Inc. Std Self Diagnostics Product Portfolio
- 8.10.5 Alere Inc. Recent Developments
- 8.11 Affymetrix
- 8.11.1 Affymetrix Company Information
- 8.11.2 Affymetrix Business Overview
- 8.11.3 Affymetrix Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.11.4 Affymetrix Std Self Diagnostics Product Portfolio
- 8.11.5 Affymetrix Recent Developments
- 8.12 Abbott Laboratories
- 8.12.1 Abbott Laboratories Company Information
- 8.12.2 Abbott Laboratories Business Overview
- 8.12.3 Abbott Laboratories Std Self Diagnostics Revenue and Gross Margin (2021-2026)
- 8.12.4 Abbott Laboratories Std Self Diagnostics Product Portfolio
- 8.12.5 Abbott Laboratories Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst